（来源：名城苏州网） 鲲石生物凭借其独创的四大技术平台，从根源上解决了自体CAR-M疗法"难转导、成本高、周期长、抗 肿瘤能力弱"的核心难题。 病毒改造技术突破 转自：名城苏州网 鲲石自主研发的巨噬细胞特异性病毒改造技术，将腺病毒与慢病毒对巨噬细胞的转导效率提升至90%以 上，解决CAR-M基因递送效率低下的行业难题。 BioBAY园内企业鲲石生物近日完成 5000 万元人民币 A 轮融资，用于深入推进其全球领先的巨噬细胞 药物研发及临床转化。 第三代CAR-M 本轮融资将重点用于公司全球领先的巨噬细胞药物平台建设，加速推进自主研发的第三代 CAR-M 靶向 HER2 管线的 IND 申报、一期临床进程以及胰腺癌，肺癌等管线临床前研究和 IIT 探索。此次融资的顺 利完成，不仅体现了资本市场对公司在巨噬细胞药物领域创新能力和研发进展的高度认可，也为后续临 床转化奠定了坚实基础。 鲲石全球首创第三代CAR-M串联了巨噬细胞自体增殖活化所必需的细胞因子，促进CAR-M长期存活， 改变肿瘤微环境，已经完成10例患者的IIT临床试验。 体内CAR-M技术 技术平台驱动，破解 CAR-M 成药难题 临床数据亮眼，验证" ...

Financing Activities - 修实生物医药 completed nearly 100 million RMB Series A financing, focusing on overseas market expansion and R&D investment in peptide synthesis [2] - 百达信生物 successfully raised over 30 million RMB in Pre-A financing to accelerate the construction of a GMP production base for vaccine adjuvants [2] - 迈锐迪 announced the completion of several million RMB angel round financing to develop nuclear medicine projects [3] - 星动纪元 completed nearly 1 billion RMB A+ round financing, focusing on embodied intelligence technology [3] - 蓝点触控 secured over 100 million RMB in C round financing to enhance robot control technology [4] - 鲲石生物 raised 50 million RMB in Series A financing to advance macrophage drug innovation [5] - RockFlow completed several million USD in new financing led by Ant Group, focusing on AI-driven fintech solutions [5] - 中凯信网络 raised 8 million RMB in angel round financing to enhance AI technology integration [6] - 比利信息 completed several million RMB A+ round financing to accelerate the development of a new media platform for the travel industry [6] - 易思旋磁 secured several million RMB in seed round financing to support early-stage R&D in magnetic technology [6] - 融和医疗 completed nearly 100 million RMB in B round financing to promote innovative treatments for chronic obstructive pulmonary disease [7] - 爱鸥光学 raised several million RMB A+ round financing to enhance product development in the optical field [7] - 星尘智能 completed several hundred million RMB A++ round financing, focusing on AI robotics technology [8] - 中合基因 raised several million RMB Pre-A+ round financing to accelerate the commercialization of green DNA synthesis equipment [8] - 商汤医疗 completed several hundred million RMB in strategic financing to enhance medical AI models [9] - 博思芯宇 secured several million RMB angel+ round financing to develop sustainable computing solutions [9] - 灵宇宙 completed 200 million RMB Pre-A round financing to advance AI and consumer robotics [10] - 加速进化 completed over 100 million RMB financing to enhance humanoid robotics development [10] - 基流科技 raised nearly 100 million RMB in B round financing to strengthen AI computing cluster technology [11] - 耀石锂电 completed A round financing to accelerate solid-state battery technology commercialization [12] - 广汽高域 completed 200 million RMB Pre-A round financing to advance flying car technology [12] Investment Funds - 杭州热电 plans to invest 200 million RMB in establishing an industrial investment fund [14] - 恩威医药 announced a 20 million RMB investment in a joint fund focusing on early-stage enterprises [14] - 广东省人工智能与机器人产业投资基金 was established with a total investment of 1 billion RMB [14] - 杭州润苗基金 launched with an initial scale of 2 billion RMB, focusing on early-stage tech startups [14] - 安徽海螺新兴产业股权投资基金 was established with a total investment of 1 billion RMB [14] - 湖南高速 established a 6.5 billion RMB infrastructure investment fund [14] - 农银投资 and 浦东创投 launched a 3.334 billion RMB private equity fund [14] - 烟台夹河幸福新城城市发展母基金 was established with a total investment of 1 billion RMB [14] - 上海中移数字转型私募基金 increased its capital to 6.814 billion RMB, marking a 28% increase [14] - 四川高端能源装备子基金 was established with a scale of 1.5 billion RMB [14] - 市北高新 invested 40 million RMB in a joint investment fund [14]